Literature DB >> 8465737

The left ventricle in systemic lupus erythematosus: initial observations and a five-year follow-up in a university medical center population.

T M Winslow1, M A Ossipov, G P Fazio, E Foster, J S Simonson, N B Schiller.   

Abstract

The objectives of this study were to determine the natural history of abnormalities in left ventricular size and function in patients with systemic lupus erythematosus and to determine whether changes in ventricular function can be attributed to a primary lupus cardiomyopathy. The design was a prospective 5-year follow-up study in a university hospital. There were 28 patients with systemic lupus erythematosis who were enrolled in an echocardiographic study from 1985 to 1986 and who were available for follow-up echocardiographic examinations. Patients were prospectively subgrouped according to the presence or absence of systemic hypertension. Twenty healthy volunteers participated as normal control subjects. Measurements of left ventricular mass index, mean wall thickness, volumes, and ejection fraction and Doppler indices of mitral inflow were performed on all patients and control subjects. Increases in left ventricular mass index, mean wall thickness, and end-systolic volume and decreases in ejection fraction were seen in the patients with lupus when compared with control subjects (p < or = 0.05) and were related to the presence of hypertension and coronary artery disease. In the group of patients without hypertension, no significant differences in left ventricular mass index, volumes, or ejection fraction were detected when compared with the control group. The normotensive patients did demonstrate mild abnormalities of mitral inflow that did not worsen during the follow-up period. It was concluded that abnormalities of systolic and diastolic left ventricular function are common in patients with lupus, are progressive over time, and are related to the coexistence of hypertension and coronary artery disease.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8465737     DOI: 10.1016/0002-8703(93)90123-q

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  4 in total

1.  [Cardiovascular monitoring of patients with systemic lupus erythematosus].

Authors:  H Schotte; H Becker; W Domschke; M Gaubitz
Journal:  Z Rheumatol       Date:  2005-11       Impact factor: 1.372

2.  Cardiac dysfunction in patients with systemic lupus erythematosus and antiphospholipid syndrome.

Authors:  Daphna Paran; Dan Caspi; David Levartovsky; Ori Elkayam; Ilana Kaufman; Irena Litinsky; Gad Keren; Bella Koifman
Journal:  Ann Rheum Dis       Date:  2006-11-01       Impact factor: 19.103

3.  Systolic and diastolic heart function in SLE patients.

Authors:  Margaret Wislowska; D Dereń; M Kochmański; S Sypuła; J Rozbicka
Journal:  Rheumatol Int       Date:  2009-03-25       Impact factor: 2.631

4.  Lactobacillus paracasei GMNL-32 exerts a therapeutic effect on cardiac abnormalities in NZB/W F1 mice.

Authors:  Wei-Syun Hu; Peramaiyan Rajendran; Bor-Show Tzang; Yu-Lan Yeh; Chia-Yao Shen; Ray-Jade Chen; Tsung-Jung Ho; Viswanadha Vijaya Padma; Yi-Hsing Chen; Chih-Yang Huang
Journal:  PLoS One       Date:  2017-09-21       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.